Essential Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Essential Partners's ADPT Position: Q2 2026 in Review
Essential Partners reduced its Adaptive Biotechnologies (ADPT) stake by 16% in Q2 2026, selling an estimated $1.85K and leaving 619 shares worth $13.3K. The position accounts for 0.01% of the portfolio, ranked #1083.
Essential Partners first reported a position in ADPT in Q2 2025 and has held it in 5 quarters since. The position peaked at $26.2K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Essential Partners held 619 shares of Adaptive Biotechnologies worth $13.3K as of Q2 2026.
- Essential Partners sold 121 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.85K.
- Adaptive Biotechnologies made up 0.01% of Essential Partners's portfolio in Q2 2026, its #1083 holding.
- Essential Partners first reported a position in Adaptive Biotechnologies in Q2 2025 and has held it in 5 quarters since.
- Essential Partners's Adaptive Biotechnologies position peaked at $26.2K in Q4 2025.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.